
Tanya M Laidlaw MD
Assistant Professor in Medicine, Harvard Medical School Director of Translational Research in Allergy, Brigham and Women's Hospital
Join to View Full Profile
850 Boylston StreetBrigham and Women's HospitalChestnut Hill, MA 02467
Phone+1 617-732-9850
Dr. Laidlaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
Education & Training
- Brigham and Women's HospitalFellowship, Allergy and Immunology, 2006 - 2009
- Mass General Brigham/Massachusetts General HospitalResidency, Pediatrics, 2003 - 2006
- University of Massachusetts Medical SchoolClass of 2003
Certifications & Licensure
- MA State Medical License 2006 - 2026
- American Board of Allergy and Immunology Allergy & Immunology
Clinical Trials
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin) Start of enrollment: 2012 Aug 31
- High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD) Start of enrollment: 2014 Mar 01
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban Start of enrollment: 2018 Apr 26
Publications & Presentations
PubMed
- Nasal Epithelial Extracellular Vesicles Correlate with Type 2 Inflammation During Aspirin-induced Respiratory Reactions.Kaitlyn E Bunn, Zachary J Bressman, Grant K Nation, Pingsheng Wu, Taneem Amin
American Journal of Respiratory Cell and Molecular Biology. 2025-03-14 - 2 citationsDupilumab Treatment for Aspirin-Exacerbated Respiratory Disease in a Real-World Setting: Impact on Quality of Life and Healthcare Utilization.Jyotsna Mullur, Rie Maurer, Tessa Ryan, Alanna McGill, Jillian C Bensko
American Journal of Rhinology & Allergy. 2025-03-01 - 1 citationsHuman intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling.Tahereh Derakhshan, Eleanor Hollers, Alex Perniss, Tessa Ryan, Alanna McGill
The Journal of Clinical Investigation. 2025-01-02
Journal Articles
- Original Article A One-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory DiseaseTanya Laidlaw, Geneva A DeGregorio, Katherine N Cahill, ScienceDirect
- Allergic Inflammatory Memory in Human Respiratory Epithelial Progenitor CellsNora A Barrett, Tanya M Laidlaw, Daniel F Dwyer, Joshua A Boyce, Neil Bhattacharyya, Kathleen M Buchheit, Katherine N Cahill, Nature
Authored Content
- Clinical Communications Accidental Ingestion of Aspirin and Non-Steroidal Anti-Inflammatory Drugs Is Common in Patients with Aspirin-Exacerbated Respiratory DiseaseNovember 2018
Press Mentions
- New Asthma Research Effort Aims for Better Understanding, TreatmentsJanuary 8th, 2025
- How Do AERD Patients' Self-Reports Compare with Objective Tests?February 9th, 2022
- Allergies or COVID? One Boston Expert with How to Tell:September 2nd, 2021
- Join now to see all
Grant Support
- Patient-Oriented Research Mentorship and Training in Upper Airway Allergic and Inflammatory DiseasesBRIGHAM AND WOMEN'S HOSPITAL2023–2028
Professional Memberships
- Member
External Links
- Samter's Triad/AERDhttp://aerd.partners.org
- BWH AERDhttp://www.brighamandwomens.org/Departments_and_Services/medicine/services/rheumatology/Services/aspirin-exacerbated-respiratory-disease.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: